Sanofi and Regeneron announce Kevzara® (Sarilumab) biologics license application resubmission accepted for review by US FDA

1st May 2017 Uncategorised 0

Sanofi

More: Sanofi and Regeneron announce Kevzara® (Sarilumab) biologics license application resubmission accepted for review by US FDA
Source: MDlinx